Abstract:What's new? In the United Kingdom, two thirds of breast cancers are detected at mammography. The remaining one third is found during the interval between screens. Here, using data from the Million Women Study, risk factor associations were compared for interval versus screen‐detected breast cancer. Analyses show that body mass index had a smaller positive association with the risk of interval cancer than with the risk of screen‐detected cancer. Both family history of breast cancer and previous surgery for benign breast disease had a greater positive assocition with the risk of interval cancer than with the risk of screen‐detected cancer. The findings are consistent with the effects of these risk factors on mammographic screening sensitivity. The associations of certain factors, such as age and menopausal hormone therapy, with breast cancer risk are known to differ for interval and screen‐detected cancers. However, the extent to which associations of other established breast cancer risk factors differ by mode of detection is unclear. We investigated associations of a wide range of risk factors using data from a large UK cohort with linkage to the National Health Service Breast Screening Programme, cancer registration, and other health records. We used Cox regression to estimate adjusted relative risks (RRs) and 95% confidence intervals (CIs) for associations between risk factors and breast cancer risk. A total of 9421 screen‐detected and 5166 interval cancers were diagnosed in 517,555 women who were followed for an average of 9.72 years. We observed the following differences in risk factor associations by mode of detection: greater body mass index (BMI) was associated with a smaller increased risk of interval (RR per 5 unit increase 1.07, 95% CI 1.03–1.11) than screen‐detected cancer (RR 1.27, 1.23–1.30); having a first‐degree family history was associated with a greater increased risk of interval (RR 1.81, 1.68–1.95) than screen‐detected cancer (RR 1.52, 1.43–1.61); and having had previous breast surgery was associated with a greater increased risk of interval (RR 1.85, 1.72–1.99) than screen‐detected cancer (RR 1.34, 1.26–1.42). As these differences in associations were relatively unchanged after adjustment for tumour grade, and are in line with the effects of these factors on mammographic density, they are likely to reflect the effects of these risk factors on screening sensitivity.

Long-term trends in incidence, characteristics and prognosis of screen-detected and interval cancers in women participating in the Dutch breast cancer screening programme

Exploring the trend of increased cervical intraepithelial neoplasia detection rates in the Netherlands

Trends in incidence, treatment, and relative survival of colorectal cancer in the Netherlands between 2000 and 2021

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017

An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients

Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter Analysis

Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women

Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990-2021)

Quality of life of women with a screen-detected versus clinically detected breast cancer in the Netherlands: a prospective cohort study

Breast Cancer Screening Interval: Effect on Rate of Late-Stage Disease at Diagnosis and Overall Survival

Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States

The Fluctuating Incidence, Improved Survival of Patients with Breast Cancer, and Disparities by Age, Race, and Socioeconomic Status by Decade, 1981-2010

Radiotherapy trends and variations in invasive non-metastatic breast cancer treatment in the Netherlands: a nationwide overview from 2008 to 2019

Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain

Breast cancer screening: a 35-year perspective

Differences in treatment and survival of older patients with operable breast cancer between the United Kingdom and the Netherlands - A comparison of two national prospective longitudinal multi-centre cohort studies

Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway

A comparative analysis of risk factor associations with interval and screen‐detected breast cancers: A large UK prospective study

Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers

Increasing opportunities for breast-conserving therapy in multiple ipsilateral breast cancer: Dutch nationwide study

Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study